Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.66)
# 2,117
Out of 4,911 analysts
296
Total ratings
56.83%
Success rate
-1.32%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Overweight | $25 | $19.54 | +27.94% | 1 | Jul 1, 2025 | |
| HNGE Hinge Health | Initiates: Overweight | $46 | $45.11 | +1.98% | 1 | Jun 16, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $59.41 | -32.67% | 4 | Jun 11, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $151.00 | +39.07% | 3 | Jun 9, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $355 → $410 | $333.70 | +22.86% | 3 | Jun 9, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $201 → $210 | $289.95 | -27.57% | 8 | May 29, 2025 | |
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $156.22 | +28.02% | 1 | Mar 26, 2025 | |
| ARDT Ardent Health | Maintains: Overweight | $24 → $22 | $10.92 | +101.47% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $8.74 | +20.14% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.98 | +20.48% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $123 → $97 | $133.21 | -27.18% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $4.07 | +23.00% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $71.30 | +59.89% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $32.27 | +76.63% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $68.15 | +18.86% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $60.84 | -42.47% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.32 | +25.70% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $85.27 | +116.96% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $206.07 | -18.96% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $105.31 | -60.12% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $169.24 | -6.05% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $60.27 | +107.40% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $289.52 | -75.03% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $184.94 | +5.44% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $284.72 | +71.40% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $167.92 | +76.27% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $263.32 | +39.75% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $238.24 | +115.33% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $295.55 | -6.95% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $28.25 | +211.50% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $55.84 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $66.23 | +179.33% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $221.28 | -3.74% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $121.50 | -52.26% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $226.83 | -48.42% | 15 | Jun 16, 2020 |
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $19.54
Upside: +27.94%
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $46
Current: $45.11
Upside: +1.98%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $59.41
Upside: -32.67%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $151.00
Upside: +39.07%
HCA Healthcare
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $355 → $410
Current: $333.70
Upside: +22.86%
Veeva Systems
May 29, 2025
Maintains: Underweight
Price Target: $201 → $210
Current: $289.95
Upside: -27.57%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $156.22
Upside: +28.02%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $10.92
Upside: +101.47%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $8.74
Upside: +20.14%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.98
Upside: +20.48%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $133.21
Upside: -27.18%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $4.07
Upside: +23.00%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $71.30
Upside: +59.89%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $32.27
Upside: +76.63%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $68.15
Upside: +18.86%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $60.84
Upside: -42.47%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.32
Upside: +25.70%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $85.27
Upside: +116.96%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $206.07
Upside: -18.96%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $105.31
Upside: -60.12%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $169.24
Upside: -6.05%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $60.27
Upside: +107.40%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $289.52
Upside: -75.03%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $184.94
Upside: +5.44%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $284.72
Upside: +71.40%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $167.92
Upside: +76.27%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $263.32
Upside: +39.75%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $238.24
Upside: +115.33%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $295.55
Upside: -6.95%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $28.25
Upside: +211.50%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $55.84
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $66.23
Upside: +179.33%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $221.28
Upside: -3.74%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $121.50
Upside: -52.26%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $226.83
Upside: -48.42%